np event 2254995 0E193A 1
The Evolving Science of Tyrosine Kinase 2 (TYK2) Inhibitors to Improve Outcomes in Patients With Psoriatic Arthritis
1.0

Claim your AMA PRA Category 1 Credit or CNE Contact Hour

Already have an Account? Log In
Don’t have an account? Register Today

 Claim your Certificate

course Faculty

No data was found

Related Courses

Group 39553
Cardiometabolic
Update from AHA2025: New Data on Disease Modifying Therapy in the Management of ATTR Amylo...
Group 39553
Cardiometabolic
Patient Self-Management of Acute PSVT: A Systematic Review of Etripamil Data from AHA25
np document 888746 0E193A 5
Neurology
AANEM 2025: Conference Review and Analysis for New Data on Emerging BAFF/APRIL Inhibitors ...